(888) 552-6760 SCHEDULE AN APPOINTMENT

City of Hope Cancer Center Atlanta Appoints Shady Eldaif, M.D., as Director of Thoracic Oncology

July 22, 2024

ATLANTA — City of Hope® Cancer Center Atlanta today announced the appointment of Shady Eldaif, M.D., as their new director of Thoracic Oncology. In his role, Eldaif will be responsible for the coordination of their clinical team as well as the expansion and development of treatments, techniques and technology for thoracic cancer. He will also provide direct patient care as a thoracic surgeon.

“We are excited to expand City of Hope Atlanta’s Thoracic Oncology team with such an experienced leader,” said Jonathan Watkins, president of City of Hope Atlanta. “Dr. Eldaif is well-known for his expertise and clinical leadership in the Georgia health care space. His talent and knowledge will make a considerable impact on our department to ensure we are offering leading-edge treatment options for thoracic cancer patients in the southeast.”

Eldaif has successfully completed over 1,600 complex robotic thoracic surgical cases to date and is extremely specialized in a wide array of minimally-invasive robotic and precision surgical techniques, including Ivor Lewis esophagectomy, robotic hyperthermic intraoperative chemotherapy, thymectomy, sleeve lobectomy and segmentectomy, to name a few. He joins City of Hope from Northside Hospital, where he served as a thoracic surgeon, inaugural system chief of Thoracic Surgery and director of Robotic Thoracic Oncology and Foregut Surgery. Eldaif has contributed to nearly two dozen oncology presentations; authored or contributed to almost twenty oncology publications or submissions; and has previously engaged as a research fellow with Emory University Hospital’s Cardiothoracic Research Laboratory.

Board certified as a diplomate with the American Board of Surgery and American Board of Thoracic Surgery, Eldaif’s clinical focus on thoracic surgical oncology is driven by a desire to offer curative and minimally invasive treatments that provide the maximum quality of life experience for his patients.

“I am drawn to City of Hope’s mission of curing cancer," said Eldaif. “In the modern era, we are offering more cures for more cancers, even in more advanced stages. City of Hope is one of the few programs in the country that uses the word ‘cure’ in a truly genuine way.”

To learn more about City of Hope Atlanta’s comprehensive cancer services, visit City of Hope’s website or call 855-939-HOPE.

About City of Hope

City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research and development, academics and training, and innovation initiatives. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.